Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Advaxis
Biotech
Ayala, Advaxis merger means new leadership team—Chutes & Ladders
Ayala sheds execs amid merger; Scynexis CEO leaves in C-suite shake-up; Mirror Biologics taps Scott Filosi to lead.
Gabrielle Masson
,
Max Bayer
Oct 21, 2022 9:30am
Ayala and Advaxis fuse together to pool funds for lead programs
Oct 19, 2022 11:00am
Prelude nabs $60M series B, gains biopharma veteran CMO
Jun 12, 2019 8:46am
Advaxis suffers another blow as FDA puts phase 3 on partial hold
Jan 24, 2019 7:35am
Advaxis cuts staff, seeks partner for troubled cancer vaccine
Jun 8, 2018 10:35am
Chutes & Ladders—Sanofi hires ex-Roche executive as R&D chief
Apr 27, 2018 8:00am